|
|
The Importance
of Screening for Early Detection of Colorectal Cancer
The Good News
The good
news about colorectal cancer is that it is up to 90% curable caught early enough.
That is why screening is so important.
Colorectal cancer arises
from benign growths in the colon known as polyps. The goal of screening is to
detect and remove polyps before they have the opportunity to become cancerous.
According to The Cancer Research Foundation of America as many as 30 to 40 percent
of the population over 50 has pre-cancerous adenomatous polyps. Nearly all colorectal
cancer develops from these growths in the colon and rectum.
Even if
a cancer is detected during screening, it is often small and early in stage making
curable surgery and treatment more likely.
Common Symptoms
Common symptoms
and warning signs of colorectal cancer include:
- Blood in the stool;
- A change in bowl habits;
- Diarrhea, constipation
or feeling that the bowl does not empty completely;
- Stools narrower than usual;
- General abdominal discomfort
(frequent gas pains, bloating fullness, and/or cramps);
- Weight loss with no known
reason;
- Constant tiredness.
If any of these symptoms persist,
or you have a family history of colorectal cancer you should talk to your health
care provider or a gastrointerologist.
Screening for Blood in
Stool
Frequently,
but not always, polyps become irritated and bleed. Commonly this bleeding is in
such small amounts that it is not perceptible to the human eye.
An 18-year
study released in 1999 by the Centers for Disease Control and Prevention confirms
that regular screening with a Fecal Occult Blood Test to detect occult (hidden)
blood in stool can prevent 33 percent of colorectal cancer.
Recent clinical
findings by The University of Minnesota and clinical trials in Denmark and England
also definitively confirm that screening for colorectal cancer can save lives.
Detected at its earliest stages, colorectal cancer is up to 90 percent curable.
Yet only 37 percent of colorectal cancer is detected at this stage.
Oddly enough,
although physicians now routinely recommend screening for breast, cervical and
prostate cancer screening for colorectal cancer is vastly underutilized. According
to the University of Minnesota study, only four in 10 Americans who should be
screened for colorectal cancer get the proper tests.
This may
be due to the uneasiness patients or physicians feel in discussing this subject.
However, as Dr. Bernard Levin, Chair of the National Colorectal Cancer Roundtable,
has noted, patients are at risk of literally dying of embarrassment.
Regular
screening for colorectal cancer allows disease detection of early stage cancers
which are up to 95 percent curable.
Major Screening Methods
The four
major screening methods everyone should be aware of are:
- Fecal Occult Blood
Test (FOBT). This is a low cost screening test that checks for hidden blood
in stool, one of the early warning signs of colorectal cancer. The most prevalent
form of this test requires handling of stool, dietary restrictions, and laboratory
processing: three major barriers to compliance. With EZ Detect, these common
barriers to compliance are eliminated. EZ Detect
is the only non-invasive FDA cleared FOBT that can be performed and produce results
at home that has no dietary restrictions and no handling of stool.
A positive FOBT result does
not necessarily indicate colorectal cancer. There could be false positives or
the test may also indicate ulcers, hemorrhoids, polyps, colitis, diverticulitis
or fissures which may not show visible symptoms even though they are producing
blood in the stool. EZ Detect can therefore serve as an early warning signal
of other bowel troubles that need medical attention.
A negative FOBT does not
necessarily indicate that colorectal cancer does not exist since not all polyps
bleed or bleed all the time.
An FOBT cannot detect every
colon problem or abnormality and does not replace an examination by a doctor or
other diagnostic procedures. However, according to the University of Minnesota
study, FOBTs are of great value in screening people for further examination and
colonoscopy since FOBTs are such a low cost screening tool compared to colonoscopy.
If there is a positive result with FOBT screening, the American College of Physicians
recommends colonoscopy.
In the United States, where
colonoscopy is generally safe and accessible, the preferred strategy for evaluating
a positive result on a fecal occult blood test is colonoscopy.
Recommended FOBT screening
frequency: annually.
- Colonoscopy - A
colonoscopy is generally considered the gold standard of care in screening. In
this procedure (typically performed by a gastroenterologist) a flexible tube with
a light and camera on the end (called an endoscope) is inserted into the rectum
and can visualize the entire colon. Biopsies can be taken and if identified, polyps
can be removed at the same time. This exam does not usually cause pain, although
it can be uncomfortable. (Most people say the preparation the day before the exam
is the worst part.) Patients are generally given medication through a vein to
make them feel relaxed and sleepy.
A colonoscopy usually is
performed if someone is at high risk of colon cancer or after simpler tests (such
as FOBT, sigmoidoscopy, DCBE or digital rectal exams) have found symptoms such
as bleeding.
Recommended colonoscopy
screening frequency: Every 8 to 10 years starting at age 50, or more frequently
as recommended by physician.
- Sigmoidoscopy -
A sigmoidoscopy is like a colonoscopy but only examines the lower third of the
colon.
- Double-Contrast Barium
Enema (DCBE) or Barium X-Ray - This is an x-ray examination of the rectum
and entire colon performed in a hospital or clinic. The patient is given an enema
containing white dye or barium, followed by an injection of air. The barium outlines
the intestine and enables the doctor or health professional to take x-rays of
the lower intestine.
The disadvantage of the
double contrast barium enema, however, according to the American College of Physicians,
is that an abnormal examination will require subsequent colonoscopy. "Moreover,
and in greater importance in our view, a barium enema may not detect large (>1
cm) adenomas in about 40% of cases."
Get
screened, start by ordering
your screening kit today!
Tell
your friends and family by
e-card!
REFERENCES:
- Cancer Facts and Figures 1999, The American Cancer Society
- Landis SH, Murray T, Bolden S, Wingo PA, Cancer Statistics, 1998. CA Cancer
J Clin 1998;48:6-29
- Mayberry RM, Coates RJ, Hill HA, Click LA, et al, Determinants of black/white
differences in colon cancer survival. JNCI 1995;87(22):1686-1693
- Harvard Center for Cancer Prevention, Harvard Report on Cancer Prevention
Volume I, Causes of Human Cancer. Can Causes Control 1996-7 (SI):7-15
- Byers T, Levin B, Rothenberger D, Dodd GD, et al. American Cancer Society
Guidelines for screening and surveillance for early detection of colorectal polyps
and cancer. Update 1997, CA Cancer J Clin. 1997:47:154-160.
- Ransohoff DF, Lang CA, Screening for Colorectal Cancer with the Fecal Occult
Blood Test:A Background Paper, Annals of Internal Medicine 1997, V.126,
N10, 811-822
- Comparison of Self-Reported Fecal Occult Blood Testing with Automated Laboratory
Records among Older Women in a Health Maintenance Organization. American Journal
of Epidemiology 1999:150:617-21. (September 15, 1999)
- Ransohoff DF, Lang CA. Screening for colorectal cancer with the fecal occult
blood test: a background paper. Ann Intern Med 1997;126:811-22.
- CDC. Screening for colorectal cancer -- United States, 1992-1993, and new
guidelines. MMWR 1996;45:107-10.
- Jack S. Mandel, Timothy R. Church, Fred Ederer, John H. Bond, Colorectal
Cancer Mortality: Effectiveness of Biennial Screening for Fecal Occult Blood
Jnl of the National Cancer Institute Vol. 91, No. 5, 434-437, March 3, 1999
- Bresalier RS, Rothernerger D, The American Cancer Society Guidelines for
Colorectal Cancer Screening: Have We Gone Too Far (Or Not Far Enough?) Gastroenterology
114:1341-1342, 1998
- Levin B. Colorectal Cancer Screening:Sifting Through the Evidence J Natl
Cancer Inst 91:399-400, 1999
- Whelan, Elizabeth, American Council of Science and Health, Editorial:Saving
Lives By Screening for Colon Cancer
- OnHealth:Risks
for Colon Cancer, from publishers of New England Jnl of Medicine
- National Cancer
Institute, Cancer Facts
- Jack S. Mandel, Timothy R. Church, Fred Ederer, John H. Bond, Colorectal
Cancer Mortality: Effectiveness of Biennial Screening for Fecal Occult Blood
Jnl of the National Cancer Institute Vol. 91, No. 5, 434-437, March 3, 1999
DISCLAIMER: The information provided here is not intended to replace the medical advice of your doctor or health care provider. Please consult your health care provider for advice about a specific medical condition. The information provided here is for educational purposes only. In no way should it be considered as offering medical advice. Biomerica, Inc. assumes no responsibility for how this material is used. Please check with a physician (such as a gastroenterologist) if you suspect you are ill.
|
©
Copyright 2000-2001 Biomerica, Inc. All Rights Reserved
|